In agreement with a role for FAK in tumor progression, several studies have attempted to block FAK activity to inhibit various FAK-mediated tumor malignancies22, 23, to explore FAK as a novel target for anti-cancer therapy. The gene discussed is PTK2; the disease is neoplasm.